GT Biopharma raises $3.2M in registered direct offering; issues warrants at $4.35 per share

GT Biopharma, Inc.

Gross proceeds of ~$3.2M from sale of 740,000 shares at $4.35/share in registered direct offering.
Concurrent private placement of 740,000 warrants exercisable at $4.35, five-year term.
Closing expected on or about May 23, 2024, subject to customary conditions.
Roth Capital Partners acted as exclusive placement agent; fees and expenses will be deducted.
Net proceeds to be used for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.